Electromed, Inc. Set to Join Russell 3000® Index
June 08 2020 - 4:30PM
Business Wire
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American:
ELMD), a leader in innovative airway clearance technologies, today
announced that the Company is set to join the broad-market Russell
3000® Index at the conclusion of the 2020 Russell indexes annual
reconstitution, effective after the US market opens on June 29,
according to a preliminary list of additions posted June 5,
2020.
Annual Russell indexes reconstitution captures the 4,000 largest
US stocks as of May 8, ranking them by total market capitalization.
Membership in the US all-cap Russell 3000® Index, which remains in
place for one year, means automatic inclusion in the large-cap
Russell 1000® Index or small-cap Russell 2000® Index as well as the
appropriate growth and value style indexes. FTSE Russell determines
membership for its Russell indexes primarily by objective,
market-capitalization rankings and style attributes.
Kathleen Skarvan, Electromed’s President and CEO, commented, "We
are pleased to be included on the preliminary list of additions to
the Russell 3000® Index, which further validates the success of our
strategy to grow revenue and enhance profitability with our
innovative SmartVest® Airway Clearance System. We believe that
inclusion in the Russell 3000® Index may provide additional
liquidity in Electromed’s common stock and generate greater
institutional investor awareness.”
Russell indexes are widely used by investment managers and
institutional investors for index funds and as benchmarks for
active investment strategies. Approximately $9 trillion in assets
are benchmarked against Russell’s US indexes. Russell indexes are
part of FTSE Russell, a leading global index provider. For more
information on the Russell 3000® Index and the Russell indexes
reconstitution, go to the “Russell Reconstitution” section on the
FTSE Russell website.
About Electromed, Inc.
Electromed manufactures, markets, and sells products that
provide airway clearance therapy, including the SmartVest® Airway
Clearance System, to patients with compromised pulmonary function.
The Company is headquartered in New Prague, Minnesota and was
founded in 1992. Further information about Electromed can be found
at www.smartvest.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200608005650/en/
Electromed, Inc. Mike MacCourt, Chief Financial Officer (952)
758-9299 mmaccourt@electromed.com
The Equity Group Inc. Kalle Ahl, CFA (212) 836-9614
kahl@equityny.com
Devin Sullivan (212) 836-9608 dsullivan@equityny.com
Electromed (AMEX:ELMD)
Historical Stock Chart
From May 2024 to Jun 2024
Electromed (AMEX:ELMD)
Historical Stock Chart
From Jun 2023 to Jun 2024